Top compounds associated with response to RARS2


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.006
mRNA vincristine CTRPv2 pan-cancer AAC 0.086 0.006
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.006
mRNA regorafenib CTRPv2 pan-cancer AAC 0.1 0.007
mRNA DBeQ CTRPv2 pan-cancer AAC 0.1 0.007
mRNA SB590885 GDSC1000 pan-cancer AAC -0.09 0.008
mRNA MP470 GDSC1000 pan-cancer AAC 0.094 0.008
mRNA CI-1040 GDSC1000 pan-cancer AAC -0.09 0.008
mRNA Methotrexate CTRPv2 pan-cancer AAC 0.099 0.008
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.093 0.009
Download CSV